Skip to main content

Want a detailed portfolio tracker?

Titan Pharmaceuticals Inc (de) (TTNP) Operating Margin (2016 - 2023)

Titan Pharmaceuticals Inc (de) (TTNP) operating margin from Jun 30, 2016 to Jun 30, 2023. The current Titan Pharmaceuticals Inc (de) (TTNP) operating margin is -1987.50%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Titan Pharmaceuticals Inc (de) (TTNP)

YearOperating MarginChange
2023-4044.44%
+121.40%
2022-1826.79%
+198.93%
2021-611.11%
+302.42%
2020-151.86%
-49.70%
2019-301.92%
+141.97%
2018-124.77%
-98.11%
2017-6590.91%
-22985.94%
201628.80%
-107.11%
2015-404.79%
N/A

Comparison Titan Pharmaceuticals Inc (de) (TTNP) operating margin with competitors

Titan Pharmaceuticals Inc (de) (TTNP) operating margin is -1987.50%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-23206.47%
APLMApollomics Inc - Class A431.90%-121.73%
ABUSArbutus Biopharma Corp94.30%-104.74%
SAVACassava Sciences Inc.93.36%-104.70%
RPRXRoyalty Pharma plc - Class A89.29%-104.49%
GLPGGalapagos NV84.24%-104.24%
NEUPNeuphoria Therapeutics Inc79.85%-104.02%
BDTXBlack Diamond Therapeutics Inc77.90%-103.92%
CTNMContineum Therapeutics Inc - Class A77.87%-103.92%
CVACCureVac N.V.74.59%-103.75%
IPSCCentury Therapeutics Inc67.95%-103.42%
FULCFulcrum Therapeutics Inc65.62%-103.30%
AVIRAtea Pharmaceuticals Inc63.06%-103.17%
PLXProtalix BioTherapeutics Inc62.65%-103.15%
PRTAProthena Corporation plc58.80%-102.96%
AUPHAurinia Pharmaceuticals Inc53.31%-102.68%
ADMAAdma Biologics Inc50.90%-102.56%
RPTXRepare Therapeutics Inc50.85%-102.56%
CRMDCorMedix Inc49.96%-102.51%
HCWBHCW Biologics Inc49.78%-102.50%
CPRXCatalyst Pharmaceuticals Inc49.02%-102.47%
SRPTSarepta Therapeutics Inc49.00%-102.47%
HALOHalozyme Therapeutics Inc48.98%-102.46%
KRYSKrystal Biotech Inc46.14%-102.32%
AGENAgenus Inc44.62%-102.25%
CGENCompugen Ltd43.05%-102.17%
SVASinovac Biotech Ltd42.30%-102.13%
EXELExelixis Inc41.15%-102.07%
QTTBQ32 Bio Inc39.80%-102.00%
INVAInnoviva Inc38.94%-101.96%
VRTXVertex Pharmaceuticals Inc38.10%-101.92%
NXTCNextcure Inc36.70%-101.85%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-101.69%
SLNOSoleno Therapeutics Inc33.06%-101.66%
JAZZJazz Pharmaceuticals plc31.49%-101.58%
ARGXArgen X SE30.35%-101.53%
CAICaris Life Sciences Inc - Class A30.19%-101.52%
TNGXTango Therapeutics Inc26.15%-101.32%
GMABGenmab25.11%-101.26%
ZVRAZevra Therapeutics Inc24.40%-101.23%
TECHBio-Techne Corp24.24%-101.22%
INCYIncyte Corp23.66%-101.19%
RIGLRigel Pharmaceuticals20.21%-101.02%
ICCCImmucell Corp19.01%-100.96%
REGNRegeneron Pharmaceuticals Inc17.83%-100.90%
NERVMinerva Neurosciences Inc17.73%-100.89%
HRMYHarmony Biosciences Holdings Inc17.31%-100.87%
TGTXTG Therapeutics Inc16.98%-100.85%
BMRNBiomarin Pharmaceutical Inc16.92%-100.85%
ONCBeiGene Ltd16.51%-100.83%
PTCTPTC Therapeutics Inc16.50%-100.83%
ENVBEnveric Biosciences Inc13.38%-100.67%
VXRTVaxart Inc13.19%-100.66%
VRNAVerona Pharma Plc12.90%-100.65%
ALNYAlnylam Pharmaceuticals Inc12.01%-100.60%
ASNDAscendis Pharma A/S10.06%-100.51%
APLSApellis Pharmaceuticals Inc9.86%-100.50%
FOLDAmicus Therapeutics Inc8.61%-100.43%
CGEMCullinan Oncology Inc7.24%-100.36%
IMCRImmunocore Holdings plc6.82%-100.34%
NAGENiagen Bioscience Inc5.01%-100.25%
NUVBNuvation Bio Inc - Class A4.66%-100.23%
BMEABiomea Fusion Inc2.46%-100.12%
TLXTelix Pharmaceuticals Ltd1.58%-100.08%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.04%-100.00%